Yep they have the complete data package used in the peer review and can complete their own independent DD on it.
The commercials are now just down to agreeing the mutually acceptable conditions.
- Forums
- ASX - By Stock
- PAR
- Ann: Appendix 4D and Half Year Report
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
0.00%
!
29.0¢

Ann: Appendix 4D and Half Year Report, page-36
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $112.9M |
Open | High | Low | Value | Volume |
28.5¢ | 29.5¢ | 28.0¢ | $124.5K | 435.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 13421 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 13706 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13421 | 0.285 |
17 | 266918 | 0.280 |
4 | 51034 | 0.275 |
5 | 43441 | 0.270 |
3 | 8195 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 13706 | 1 |
0.300 | 16317 | 2 |
0.310 | 115169 | 4 |
0.315 | 59233 | 3 |
0.320 | 142591 | 7 |
Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |